Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Adefovir dipivoxil |
Hepsera |
[[Image: ...
Wikipedia - [full article]
Adefovir dipivoxil Clinical Trials
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00307242 - Recruiting
Chronic Hepatitis B
- Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children
ClinicalTrials.gov Identifier: NCT00002219 - Active, not recruiting
HIV Infections
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
Chronic Hepatitis B
- Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00095121 - Active, not recruiting
Chronic Hepatitis B
- The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001082 - Active, not recruiting
Cytomegalovirus Infections; HIV Infections
- A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination with Anti-HIV Therapy (HAART) in HIV-Positive Patients
ClinicalTrials.gov Identifier: NCT00002426 - Completed
HIV Infections
- A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3
ClinicalTrials.gov Identifier: NCT00002161 - Completed
HIV Infections
- Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)phosphonylmethoxyethyl]adenine (bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002128 - Completed
HIV Infections
- A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated with Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00002206 - Completed
HIV Infections
- The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children
ClinicalTrials.gov Identifier: NCT00000843 - Completed
HIV Infections
- An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients with Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
ClinicalTrials.gov Identifier: NCT00042393 - Completed
Chronic Hepatitis B
- A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00117676 - Active, not recruiting
Chronic Hepatitis B
- Telbivudine Versus Adefovir Dipivoxil in Adults with HBegAg-Positive, Compensated Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00115245 - Completed
Chronic Hepatitis B
- A Study to Compare Tenofovir versus Hepsera (adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00116805 - Active, not recruiting
Chronic Hepatitis B
- Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success with Nelfinavir
ClinicalTrials.gov Identifier: NCT00002220 - Completed
HIV Infections
- Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
ClinicalTrials.gov Identifier: NCT00002419 - Completed
HIV Infections
- Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002234 - Completed
HIV Infections
- A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies with Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (R
ClinicalTrials.gov Identifier: NCT00002184 - Completed
HIV Infections
- Lamivudine and Adefovir to Treat Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00023309 - Recruiting
HBV; Hepatitis B; Hepatitis; Liver
- The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined with Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00002379 - Completed
HIV Infections
- Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
ClinicalTrials.gov Identifier: NCT00307489 - Active, not recruiting
Chronic Hepatitis B
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
ClinicalTrials.gov Identifier: NCT00403585 - Active, not recruiting
Chronic Hepatitis B
- A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy
ClinicalTrials.gov Identifier: NCT00489151 - Recruiting
Hepatitis B
- Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients
ClinicalTrials.gov Identifier: NCT00316719 - Active, not recruiting
Chronic Hepatitis B
- Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a
ClinicalTrials.gov Identifier: NCT00199732 - Active, not recruiting
Chronic Hepatitis B
- Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00531167 - Recruiting
Chronic Hepatitis B
- Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
ClinicalTrials.gov Identifier: NCT00441974 - Recruiting
Chronic Hepatitis B
- Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations
ClinicalTrials.gov Identifier: NCT00002398 - Completed
HIV Infections
- A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV
ClinicalTrials.gov Identifier: NCT00033163 - Completed
HIV Infections; Hepatitis B
- Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00013702 - Completed
Hepatitis B; HIV Infection
- Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone
ClinicalTrials.gov Identifier: NCT00376259 - Recruiting
Hepatitis B
- Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
ClinicalTrials.gov Identifier: NCT00023153 - Completed
HIV Infections; Chronic Hepatitis B
- Comparative Trial of Entecavir versus Adefovir in the Treatment of Chronic Hepatitis B Infection
ClinicalTrials.gov Identifier: NCT00096785 - Active, not recruiting
Hepatitis B; Chronic Disease
- Entecavir Plus Adefovir Versus Entecavir or Adefovir Monotherapy for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
ClinicalTrials.gov Identifier: NCT00410202 - Recruiting
Hepatitis B, Chronic
- The Safety and Effectiveness of bis-POM PMEA in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002346 - Completed
HIV Infections
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
ClinicalTrials.gov Identifier: NCT00000892 - Completed
HIV Infections
- Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
ClinicalTrials.gov Identifier: NCT00158704 - Terminated
Hepatitis B
- Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
ClinicalTrials.gov Identifier: NCT00347009 - Completed
Chronic Hepatitis B; Fibrosis; Cirrhosis
- A Study on Amprenavir in Combination with Other Anti-HIV Drugs in HIV-Positive Patients
ClinicalTrials.gov Identifier: NCT00000912 - Completed
HIV Infections
- Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination with Nucleoside Analogs: A Rollover Study for ACTG 320
ClinicalTrials.gov Identifier: NCT00000885 - Completed
HIV Infections
- The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined with Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00001087 - Completed
HIV Infections
- Effect of Age on the Renal Clearance of Adefovir
ClinicalTrials.gov Identifier: NCT00187746 - Recruiting
Healthy Volunteer
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy
ClinicalTrials.gov Identifier: NCT00409019 - Recruiting
Chronic Hepatitis B
- A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.
ClinicalTrials.gov Identifier: NCT00002115 - Completed
HIV Infections
- Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)
ClinicalTrials.gov Identifier: NCT00371761 - Recruiting
Hepatitis B, Chronic
- The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002326 - Completed
HIV Infections
- Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients with Hepatic Decompensation
ClinicalTrials.gov Identifier: NCT00065507 - Recruiting
Hepatitis B
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
ClinicalTrials.gov Identifier: NCT00496002 - Recruiting
Chronic Hepatitis; Hepatitis B
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
ClinicalTrials.gov Identifier: NCT00496158 - Recruiting
Chronic Hepatitis; Hepatitis B
- Treatment of Hepatitis in Patients who are Triple-Infected with HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00051077 - Terminated
HIV Infections; Hepatitis B; Hepatitis C
Resources
- Adefovir dipivoxil (Drug Digest)
- Hepsera (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
